Construction and identification of recombinant adenovirus vector containing the hVEGF165 gene

Liu Qigong , Lu Zaiying , Zhang Weidong , Yan Jin

Current Medical Science ›› 2000, Vol. 20 ›› Issue (3) : 186 -189.

PDF
Current Medical Science ›› 2000, Vol. 20 ›› Issue (3) : 186 -189. DOI: 10.1007/BF02886984
Article

Construction and identification of recombinant adenovirus vector containing the hVEGF165 gene

Author information +
History +
PDF

Abstract

To construct the recombinant adenovirus vector containing the cDNA for human vascular endothelial growth factor (hVEGF165), the cDNA for hVEGF165 was subcloned into pACCMV · pLpA. Subsequently, this recombinant pACCMV · hVEGF was co-transfected into 293 cells together with pJM17 to obtain the replication-deficient recombinant adenovirus containing hVEGF gene — Ad-CMV · hVEGF. The VEGF gene expression was detected by using RT-PCR and Western blot in rabbit aorta vascular smooth muscle cells (VSMC) infected with AdCMV · hVEGF. Cultured human umbilical vein endothelial cells (HUVEC) were incubated with the conditioned medium (CM) from above mentioned VSMC infected with AdCMV · hVEGF to observe the effect of VEGF on proliferation of HUVEC. 48 h after the infection with AdCMV · hVEGF, VSMC demonstrated VEGF expression, and the expressed VEGF could stimulate the proliferation of HUVECin vitro. Successfully prepared AdCMV · hVEGF165 could express biologically active VEGF in infected VSMC, and stimulate proliferation of HUVEC.

Keywords

vascular endothelial growth factor / adenovirus / gene therapy / vascular smooth muscle cells

Cite this article

Download citation ▾
Liu Qigong, Lu Zaiying, Zhang Weidong, Yan Jin. Construction and identification of recombinant adenovirus vector containing the hVEGF165 gene. Current Medical Science, 2000, 20(3): 186-189 DOI:10.1007/BF02886984

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

HariawalaM, HorowitzJ R, EsakofD, et al.. VEGF accelerates collateral development in porcine hearts. J Surg Res, 1996, 63: 77-77

[2]

TakeshitaS, WeirL, ChenD F, et al.. Therapeutic angiogenesis following arterial gene transfer of VEGF in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun, 1996, 227(2): 628-628

[3]

IsnerJ M, PieczekA, SchainfeldR, et al.. Early report: clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet, 1996, 348: 370-370

[4]

IsnerJ M, PieczekA, SchainfeldR, et al.. Arterial gene transfer of naked DNA in patients with critical limb ischemia. Circulation, 1996, 94(8): I-591

[5]

ValeP R, LosordoD W, SymesJ F, et al.. Gehe therapy for myocardial angiogenesis. Circulation, 1998, 98(1): I-322

[6]

AsaharaT, ChenD H, TsurumiY, et al.. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation, 1996, 94: 3291-3291

[7]

BelleE V, TioF O, ChenD H, et al.. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol, 1997, 29: 1371-1371

[8]

LaitinenM, HartikainenJ, EranenJ, et al.. Catheter-mediated VEGF gene transfer to human coronary arteries after angioplasty. Safety results from phase I Kuopio Angioplasty Gene Transfer Trial (KAT Trial). Circulation, 1998, 98(1): 1-322

[9]

1987, 16(4):260

[10]

SambrookJ, FritschE F, ManiatisT, et al.. Molecular Cloning, 19892nd ed.WuhanCold Spring Harbor Laboratory Press

[11]

WilsonL, BeckerTC.. Methods in Cell Biology, 1994WuhanAcademic Press174-174

[12]

DNA 1990, 13(2):91

AI Summary AI Mindmap
PDF

96

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/